Retroviruses Scholarship, Community Press, Other Deadlines Soon

The annual Retroviruses conference, one of the world's most important scientific meetings on HIV, will not take place until February 2003, but scholarship and other deadlines are approaching. For community members without an accepted scientific abstract, the scholarship or community press applications are the only way to get into this meeting. Therefore some will need to apply for the scholarship whether or not they need the money.

This year the 10th Conference on Retroviruses and Opportunistic Infections will be held in Boston for the first time, at the Hynes Convention Center, February 10-14, 2003.

Deadlines by Date

• For scientists, abstracts are due October 23 at 5:30 Eastern time (except late breakers).
  Advertisement
• Also for scientists, the Fellow Travel Grant applications are due October 23.

• For international scholarships, the application deadline is November 1.

• For U.S. community scholarships, the deadline is November 8.

• For community press, the deadline is also November 8.

• Preferred registration and housing for invited speakers and authors of accepted abstracts (two per abstract) is open November 18-29.

• Registration for other researchers and clinicians (without an accepted abstract) is open December 2-January 10. Caution -- sometimes this conference fills almost immediately; in case that happens these applications must be sent as soon as this period begins. This year the conference will accept 3,800 registrations.

• The late breaker abstract deadline is January 6 at 5:30 Eastern time.

Be sure to check the conference Web site, www.retroconference.org, to confirm these dates and to get the forms and other information needed to apply.

ISSN # 1052-4207

Copyright 2002 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.

---

This article was provided by AIDS Treatment News. It is a part of the publication AIDS Treatment News.